Rholence Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2010.
2010 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Rholence Pharmaceuticals Private Limited

Rholence Pharmaceuticals Private Limited, a active private limited company, was established on 12 February 2010 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH2010PTC200028. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Pratima Rajendra Dhole (Director), Rajendra Sheshrao Dhole (Director). Past directors included Kiran Ravindra Dhole, Ravindra Sheshrao Dhole. It holds ₹0.89 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 103, New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur, Maharashtra, 440024.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2010PTC200028

  • Registration Number

    200028

  • Incorporation Date

    12 February 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.89 M
  • Revenue Growth **** 6.30%
  • Profit Growth **** 130.54%
  • Ebitda **** 172.06%
  • Net Worth 0.60%
  • Total Assets -4.02%
Company report

Rholence Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Rholence Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rholence Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pratima Rajendra Dhole Director 12 Feb 2010 Current
Rajendra Sheshrao Dhole Director 12 Feb 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Dec 2018 Past
Pramod Abcsdd Director 07 Dec 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rholence Pharmaceuticals.

Rholence Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 6.3% increase. The company also saw a substantial improvement in profitability, with a 130.54% increase in profit. The company's net worth moved up by a moderate rise of 0.6%.

Rholence Pharmaceuticals revenue growth over time
Rholence Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.30%
*******
*******
*******
*******
Revenue from Operations
*******
 6.30%
*******
*******
*******
*******
Total Assets
*******
 -4.02%
*******
*******
*******
*******
Profit or Loss
*******
 130.54%
*******
*******
*******
*******
Net Worth
*******
 0.60%
*******
*******
*******
*******
EBITDA
*******
 172.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rholence Pharmaceuticals?

In 2021, Rholence Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹892,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.09 Cr
Latest Charge Details
Date Lender Amount Status
08 Jun 2020 Others ₹0.09 M Open
28 Feb 2019 Others ₹0.80 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Rholence Pharmaceuticals?

Unlock and access historical data on people associated with Rholence Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rholence Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rholence Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rholence Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Rholence Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Rholence Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.09 M with Charge ID 100358637 was registered on 08 Jun 2020. was documented.

  • Charges

    A charge with Others amounted to Rs. 0.80 M with Charge ID 100248337 was registered on 28 Feb 2019. was recorded as a recent event.

  • Director Appointment

    The activity Pratima Rajendra Dhole was appointed as a Director was appointed as a Director on 12 Feb 2010 & has been associated with this company since 16 years 2 months . was completed.

  • Director Appointment

    Rajendra Sheshrao Dhole was appointed as a Director was appointed as a Director on 12 Feb 2010 & has been associated with this company since 16 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rholence Pharmaceuticals Private Limited?

The CIN of Rholence Pharmaceuticals Private Limited is U24100MH2010PTC200028.

Where is Rholence Pharmaceuticals Private Limited headquartered?

Rholence Pharmaceuticals Private Limited is headquartered at 103, New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur, Maharashtra, 440024.

When was Rholence Pharmaceuticals Private Limited incorporated?

Rholence Pharmaceuticals Private Limited was incorporated on 12 February 2010.

Who are the current directors of Rholence Pharmaceuticals Private Limited?

The current directors of Rholence Pharmaceuticals Private Limited are

What is the primary industry of Rholence Pharmaceuticals Private Limited?

The primary industry of Rholence Pharmaceuticals Private Limited is Trade.

Is Rholence Pharmaceuticals Private Limited a listed company?

Rholence Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Rholence Pharmaceuticals Private Limited?

The authorized capital of Rholence Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Rholence Pharmaceuticals Private Limited?

The compliance status of Rholence Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available